Market Reports Center One Stop Market Reaserch Shop Global Human Albumin Market to grow at a CAGR of 4.97% during the period 2016-2020 Summary Technavio Announces the Publication of its Research Report – Global Human Albumin Market 20162020 Technavio recognizes the following companies as the key players in the global human albumin market: CSL Behring, Grifols, Baxalta, Octapharma, and Kedrion. Other Prominent Vendors in the market are: AADi, Ablynx, Albumedix, Ampio Pharmaceuticals, Azaya Therapeutics, Beijing Tiantan, Biotest, Bristol-Myers Squibb, Celgene, ConjuChem, GSK, Hebei Changshan Biochem Pharma, HiMedia Laboratories, Hualan Biological Engineering, InVittria, MedxBio, Merck, Mitsubishi Tanabe Pharma, NantBioScience, Novo Nordisk, Novozymes, Shanghai RAAS Blood Products, Sucampo Pharmaceuticals, Teva Pharmaceuticals, Thermo Fisher Scientific, Tianjin SinoBiotech & Beijing Bio-Fortune, Ventria Bioscience, and Yoshitomi Pharmaceutical. Browse Detail Report With TOC @ https://marketreportscenter.com/reports/316888/global-human-albumin-market-2016-2020 Commenting on the report, an analyst from Technavio’ s team said: “A trend helping to propel market growth is the rise in non-therapeutic applications. Non-therapeutic applications of albumin are on a rise. Research is yet to evaluate the applications of albumin as an excipient for commercial use. Some areas where albumin can be employed are as a drug-formulating agent, an ingredient in vaccines and sealant in surgeries, and to coat medical devices and equipment. Though the current supply of albumin for nontherapeutic purposes is low, the high interest shown by the research institutes and pharmaceutical and biopharmaceutical companies in investigating the potential non-therapeutic uses of albumin is expected to drive the market.” Market Reports Center One Stop Market Reaserch Shop According to the report, a key driver is the high demand for human albumin in China. China is the largest market for albumin products. Albumin is being used as a volume replacement therapy and for treating kidney diseases, cirrhosis, and cancer. But the demand for plasma products, primarily albumin and immunoglobulins, is outstripping the supply. This is because of the stringent regulations imposed on the supply of raw materials and ban in the import of plasma products. Because of the increased demand for albumin products, the ban on import of plasma products did not include albumin Further, the report states that one challenge that could curtail market growth is the spread of pathogenic contaminants. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. About the Human Albumin Market Albumin-based therapies such as Idelvion (CSL654 rIX-FP) by CSL Behring received marketing approval from the US FDA in March 2016 and from the EMA in May 2016. Apart from these, Albutropin (TV-1106) by Teva Pharmaceuticals, Ampion by Ampio Pharmaceuticals, and Albutein by Grifols (for Alzheimer's disease) are expected to enter the market during the forecast period. The demand for albumin is high in APAC in countries like India and China. Still, the uptake of these therapeutics is less due to the lack of awareness about these products and their therapeutic uses. Thus, the awareness programs conducted by organizations such as PPTA, which includes International Plasma Awareness Week, to help increase the awareness about plasma donation and the different plasma protein therapies available, along with their potential uses, is expected to increase the uptake of these therapeutics in treating various conditions. Technavio’ s analysts forecast the global human albumin market to grow at a CAGR of 4.97% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global human albumin market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generic albumin drugs used to treat infections, liver diseases, shock, during surgery, and severe burns. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched in the market along with the decline in revenues from the genericization of the marketed drugs during the forecast period. The market is divided into the following segments based on geography: • Americas • APAC Market Reports Center One Stop Market Reaserch Shop • EMEA Technavio's report, Global Human Albumin Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors • CSL Behring • Grifols • Baxalta • Octapharma • Kedrion Other prominent vendors • AADi • Ablynx • Albumedix • Ampio Pharmaceuticals • Azaya Therapeutics • Beijing Tiantan • Biotest • Bristol-Myers Squibb • Celgene • ConjuChem • GSK • Hebei Changshan Biochem Pharma • HiMedia Laboratories • Hualan Biological Engineering • InVittria • MedxBio • Merck • Mitsubishi Tanabe Pharma • NantBioScience • Novo Nordisk • Novozymes • Shanghai RAAS Blood Products • Sucampo Pharmaceuticals • Teva Pharmaceuticals • Thermo Fisher Scientific • Tianjin SinoBiotech & Beijing Bio-Fortune • Ventria Bioscience • Yoshitomi Pharmaceutical Market Reports Center One Stop Market Reaserch Shop Market driver • High demand for human albumin in China • For a full, detailed list, view our report Market challenge • Spread of pathogenic contaminants • For a full, detailed list, view our report Market trend • Rise in non-therapeutic applications • For a full, detailed list, view our report Key questions answered in this report • What will the market size be in 2020 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? You can request one free hour of our analyst’ s time when you purchase this market report. Details are provided within the report. Request A Sample copy of This Report @ https://marketreportscenter.com/request-sample/316888 Table Of Content PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Plasma therapeutics: An overview • Components of blood plasma • Derivation of various plasma therapeutics PART 06: Global plasma therapeutics market • Market overview Market Reports Center One Stop Market Reaserch Shop • Market size and forecast PART 07: Plasma fractionation market • Overview • Market size and forecast • Market players PART 08: Albumin: An overview • Types of albumin • Albumin in human body • Clinical uses PART 09: Pipeline portfolio PART 10: Global albumin market To Get Discount On The Report @ https://marketreportscenter.com/request-discount/316888 About Us: Market Reports Centeris an e-commerce platform obliging the needs of knowledge workers, experts, professionals who are subject to market research information for their work, or to make strategic business decisions. We are dedicated to create a comprehensive offering of market research which is accurate, credible and affordable. Market Reports Center currently has more than 1,20,000 plus titles and 30+ Publishers on our platform and growing consistently. We cover more than 35 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Construction, Agriculture, Food, Beverages, Banking & Finance, Media and Government, Public Sector Studies. Contact Information: Sam Collins Market Reports Center 1-646-883-3044 (US) [email protected] https://marketreportscenter.com

According to the report, a key driver is the high demand for human albumin in China. China is the largest market for albumin products. Albumin is being used as a volume replacement therapy and for treating kidney diseases, cirrhosis, and cancer. But the demand for plasma products, primarily albumin and immunoglobulins, is outstripping the supply. This is because of the stringent regulations imposed on the supply of raw materials and ban in the import of plasma products.